TLR4 and Alzheimer disease: With all these aspects in mind, we hypothesized a multitargets drug, TLR4 inducer and P-gp/BCRP upregulating agent, simultaneously able to protect neurons by AD progression and in the meantime to activate the neuroreparative steps by maintaining stem cells in undifferentiated state.